Curis Stock (NASDAQ: CRIS) stock price, news, charts, stock research, profile.
Open | $6.91 |
Close | $6.98 |
Volume / Avg. | 34.40K / 28.06K |
Day Range | 6.90 - 7.09 |
52 Wk Range | 3.80 - 17.49 |
Market Cap | $42.85M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 0.65% |
Days to Cover | 1.14 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Curis (NASDAQ:CRIS) through any online brokerage.
Other companies in Curis’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX) and OncoCyte (NASDAQ:OCX).
There is no analysis for Curis.
Curis has a consensus price target of $16.25.
The stock price for Curis (NASDAQ: CRIS) is $7.27 last updated July 12, 2024 at 7:30 PM EDT.
There are no upcoming dividends for Curis.
Curis’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Curis.
Curis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.